RNTX earnings: a negative outcome, -7.4%

On March 28, 2022, Rein Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.4% in the window around the event. It had already run +37.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.